Scancell (LON:SCLP) Stock Price Up 29.8% - Here's Why

Scancell Holdings plc (LON:SCLP - Get Free Report) shot up 29.8% on Monday . The company traded as high as GBX 11.38 ($0.15) and last traded at GBX 11 ($0.15). 10,537,342 shares changed hands during trading, an increase of 1,073% from the average session volume of 897,982 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Stock Up 5.5 %

The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The firm's fifty day moving average price is GBX 8.58 and its 200-day moving average price is GBX 10.80. The company has a market cap of £109.27 million, a price-to-earnings ratio of -16.18 and a beta of 0.35.

Scancell (LON:SCLP - Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. Sell-side analysts predict that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.

About Scancell

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.